M3P Stock Chart & Stats
€4.12
-€0.08(-1.95%)
At close: 4:00 PM EDT
€4.12
-€0.08(-1.95%)
Day’s Range― - ―
52-Week Range€3.39 - €5.35
Previous CloseN/A
Volume0.00
Average Volume (3M)372.00
Market Cap
€2.52B
Enterprise Value€12.01K
Total Cash (Recent Filing)€425.00M
Total Debt (Recent Filing)€9.77B
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Aug 10, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding598,100,000
10 Day Avg. Volume0
30 Day Avg. Volume372
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)0.65
Price to Sales (P/S)3.09
P/FCF Ratio13.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€5.13Price Target Upside24.46% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)0.12
Revenue Forecast (FY)€889.20M
Bulls Say, Bears Say
Bulls Say
Stable Lease-based Revenue ModelMPT’s core business is long-term, often triple-net hospital leases with contractual escalators, which generate predictable recurring rent. That structural lease model supports steady cash inflows and underwriting discipline, providing durable revenue visibility over months to years.
Positive Operating And Free Cash FlowDespite accounting net losses, the company has produced positive operating and free cash flow across recent periods, which supports dividend funding, debt service and reinvestment. This cash-generation ability is a durable buffer while earnings recovery and capital structure work progress.
Governance Continuity And Management SupportStrong shareholder approval of the board, auditor and incentive plan signals continuity in oversight and management alignment with long-term strategy. This governance stability reduces execution risk on portfolio and capital decisions over the medium term.
Bears Say
Persistent Net LossesConsecutive annual net losses indicate the company has not returned to positive reported earnings, which erodes retained earnings and reduces margins available to cushion shocks. Persistent unprofitability constrains long-term earnings resilience and raises risk for dividend sustainability absent structural improvement.
Elevated LeverageDebt above ~2.1x equity and materially reduced equity levels limit financial flexibility, amplify refinancing and interest-rate risk, and constrain capacity for acquisitions or opportunistic redeployments. Elevated leverage increases vulnerability to operator stress and capital-market dislocations.
Tenant/operator Concentration RiskReliance on a concentrated set of hospital operators concentrates cash-flow risk: operator distress, reimbursement changes or insolvencies can materially reduce rent and occupancy. Concentration amplifies downside to cash generation and complicates diversification of earnings over the medium term.
Medical Properties Trust News
M3P FAQ
What was Medical Properties Trust’s price range in the past 12 months?
Medical Properties Trust lowest stock price was €3.38 and its highest was €5.35 in the past 12 months.
What is Medical Properties Trust’s market cap?
Medical Properties Trust’s market cap is €2.52B.
When is Medical Properties Trust’s upcoming earnings report date?
Medical Properties Trust’s upcoming earnings report date is Aug 10, 2026 which is in 10 days.
How were Medical Properties Trust’s earnings last quarter?
Medical Properties Trust released its earnings results on Apr 30, 2026. The company reported €0.043 earnings per share for the quarter, beating the consensus estimate of €0.024 by €0.019.
Is Medical Properties Trust overvalued?
According to Wall Street analysts Medical Properties Trust’s price is currently Undervalued.
Does Medical Properties Trust pay dividends?
Medical Properties Trust does not currently pay dividends.
What is Medical Properties Trust’s EPS estimate?
Medical Properties Trust’s EPS estimate is <0.01.
How many shares outstanding does Medical Properties Trust have?
Medical Properties Trust has 598,100,000 shares outstanding.
What happened to Medical Properties Trust’s price movement after its last earnings report?
Medical Properties Trust reported an EPS of €0.043 in its last earnings report, beating expectations of €0.024. Following the earnings report the stock price went down -1.506%.
Which hedge fund is a major shareholder of Medical Properties Trust?
Currently, no hedge funds are holding shares in DE:M3P
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medical Properties Trust Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€5.13 (24.46% Upside)
€5.13 (24.46% Upside)
Blogger Sentiment
Bullish
DE:M3P Sentiment 71%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.12%
12-Months-Change
Fundamentals
Return on Equity
7.39%
Trailing 12-Months
Asset Growth
-0.61%
Trailing 12-Months
Company Description
Medical Properties Trust
Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive property holdings encompass a diverse array of medical establishments, such as rehabilitation centers, extended-stay acute care hospitals, outpatient surgical facilities, hospitals catering to women and children, community and regional general hospitals, medical office complexes, and various other specialized care sites. The trust was established in 2003 by its co-founders, Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, with its principal offices situated in Birmingham, Alabama.
M3P Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed multiple operational and financial positives — meaningful year-over-year EBITDARM gains across core segments (general acute and rehab), strategic lease restructurings (Vibra), selective accretive acquisitions, progress on Prospect recoveries, and clear targets for cash rent and rent ramp-through 2026. Offsetting these positives are isolated but material challenges: behavioral health softness (U.K. funding and U.S. labor pressures), lingering Prospect-related impairments and remaining collections, HSA cash-collection shortfalls (with remediation tied to a Q2 EMR implementation), and several near-term debt maturities that require refinancing actions. Overall, management presented confidence in portfolio resilience and multiple tactical options to address capital needs.View all DE:M3P earnings summariesM3P Stock 12 Month Forecast
Average Price Target
€5.13
▲(24.46% Upside)
Technical Analysis
LTC Properties
―
National Health Investors
―
Sabra Healthcare REIT
―
Diversified Healthcare Trust
―
CareTrust REIT
―